US Patent 11654300 Joint optimization of radionuclide and external beam radiotherapy
Patent 11654300 was granted and assigned to RefleXion Medical on May, 2023 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11654300 Joint optimization of radionuclide and external beam radiotherapy
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.